
Organized and self-motivated research scientist and senior manager with over 12 years of specialized experience in infectious diseases, including Staphylococcus aureus, Streptococcus pneumoniae, Clostridium difficile, and Bacillus anthracis. Recognized for exceptional multitasking abilities and collaborative teamwork, leveraging strong expertise in these fields alongside outstanding interpersonal and scientific communication skills to drive significant contributions across diverse projects. Proven track record in testing clinical samples and conducting pre-clinical serology testing across multiple assays, complemented by extensive experience in virology stability testing and the development of innovative product candidates targeting staph, anthrax, pneumonia, and C. diff infections. A dedicated focus on staph infection research has led to novel discoveries and original publications, underpinned by proprietary technologies such as Infection Site Targeted Antitoxin Antibody (ISTAb) and Infection Site Targeted Universal Bridging Antigen (ISTuBA).
Conducted clinical sample testing and preclinical serology assays, including ELISA neutralization assays and immune profiling across various experimental systems. Assisted in data analysis processes to support informed decision-making in preclinical studies.
Utilized expertise in virology and pseudovirus-based neutralization systems to spearhead advancements across multiple MARV platforms.